Extracellular Matrix Protein CCN1 Limits Oncolytic Efficacy in GliomaAmy Haseley, Balveen Kaur, Ji Young Yoo et al.|Cancer Research|2012Cited by 58
Oncolytic Herpes Virus Armed with Vasculostatin in Combination with Bevacizumab Abrogates Glioma Invasion via the CCN1 and AKT Signaling PathwaysYusuke Tomita, Isao Date, Toshihiko Shimizu et al.|Molecular Cancer Therapeutics|2019Cited by 35
Implications of immune cells in oncolytic herpes simplex virotherapy for gliomaYoshihiro Otani, Balveen Kaur, Ji Young Yoo et al.|Brain Tumor Pathology|2022Cited by 21
Supplementary Tables 1-2, Figures 1-7 from Extracellular Matrix Protein CCN1 Limits Oncolytic Efficacy in GliomaAmy Haseley, Balveen Kaur, Michael A. Caligiuri et al.|Unknown|2023Cited by 0
Supplementary Figure Legends 1-7 from Extracellular Matrix Protein CCN1 Limits Oncolytic Efficacy in GliomaAmy Haseley, Balveen Kaur, Sean Boone et al.|Unknown|2023Cited by 0